[go: up one dir, main page]

NO20003693L - Beroligende feromoner for svin for Õ minske stress, angst og aggressivitet - Google Patents

Beroligende feromoner for svin for Õ minske stress, angst og aggressivitet

Info

Publication number
NO20003693L
NO20003693L NO20003693A NO20003693A NO20003693L NO 20003693 L NO20003693 L NO 20003693L NO 20003693 A NO20003693 A NO 20003693A NO 20003693 A NO20003693 A NO 20003693A NO 20003693 L NO20003693 L NO 20003693L
Authority
NO
Norway
Prior art keywords
aggressiveness
anxiety
pheromones
soothing
pigs
Prior art date
Application number
NO20003693A
Other languages
English (en)
Other versions
NO20003693D0 (no
NO329205B1 (no
Inventor
Patrick Pageat
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31950877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003693(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fideline filed Critical Fideline
Publication of NO20003693D0 publication Critical patent/NO20003693D0/no
Publication of NO20003693L publication Critical patent/NO20003693L/no
Publication of NO329205B1 publication Critical patent/NO329205B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Inorganic Insulating Materials (AREA)
NO20003693A 1998-01-21 2000-07-19 Sammensetninger omfattende feromoner, opplosning inneholdende disse samt anvendelse av sammensetningene NO329205B1 (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/010,515 US6077867A (en) 1998-01-21 1998-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
CA2227706A CA2227706C (en) 1998-01-21 1998-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
JP00980298A JP4750232B2 (ja) 1998-01-21 1998-01-21 ストレス、不安および攻撃性を低減するブタ鎮静フェロモン
NO980282A NO308197B1 (no) 1998-01-21 1998-01-21 Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav
EP98400117A EP0948963B1 (en) 1998-01-21 1998-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
PCT/EP1999/000375 WO1999037297A1 (en) 1998-01-21 1999-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
CZ20002700A CZ20002700A3 (cs) 1998-01-21 1999-01-21 Uklidňující feromonové prostředky pro snížení stresu, úzkosti a agresivity prasat

Publications (3)

Publication Number Publication Date
NO20003693D0 NO20003693D0 (no) 2000-07-19
NO20003693L true NO20003693L (no) 2000-09-20
NO329205B1 NO329205B1 (no) 2010-09-13

Family

ID=31950877

Family Applications (2)

Application Number Title Priority Date Filing Date
NO980282A NO308197B1 (no) 1998-01-21 1998-01-21 Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav
NO20003693A NO329205B1 (no) 1998-01-21 2000-07-19 Sammensetninger omfattende feromoner, opplosning inneholdende disse samt anvendelse av sammensetningene

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO980282A NO308197B1 (no) 1998-01-21 1998-01-21 Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav

Country Status (21)

Country Link
US (2) US6077867A (no)
EP (2) EP0948963B1 (no)
JP (1) JP4750232B2 (no)
CN (1) CN1217659C (no)
AT (2) ATE239464T1 (no)
AU (1) AU760614B2 (no)
BR (1) BRPI9907151C1 (no)
CA (2) CA2227706C (no)
CZ (1) CZ20002700A3 (no)
DE (2) DE69814343T2 (no)
DK (2) DK0948963T3 (no)
ES (2) ES2198661T3 (no)
HU (1) HU226882B1 (no)
IL (1) IL137257A0 (no)
NO (2) NO308197B1 (no)
NZ (1) NZ505813A (no)
PL (1) PL199144B1 (no)
PT (2) PT948963E (no)
SK (1) SK285905B6 (no)
WO (1) WO1999037297A1 (no)
ZA (1) ZA99426B (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
JP4754688B2 (ja) * 1998-01-21 2011-08-24 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
US6054481A (en) * 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
CA2388754C (en) * 1999-10-13 2010-07-13 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
AU6608201A (en) * 2000-07-14 2002-02-05 Nestle Sa Dietary lipids for improving skin and coat of pets
FR2815227B1 (fr) * 2000-10-17 2003-04-11 Schwartz Laboratoires Robert Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
ES2186576B1 (es) * 2001-10-11 2004-09-16 Universitat De Les Illes Balears Acido 2-hidroxioleico para utilizar como medicamento.
DE60332635D1 (de) * 2002-06-19 2010-07-01 Fideline Le Rieu Neuf Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
CA2490681C (en) * 2002-06-19 2012-01-24 Fideline Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
KR100700884B1 (ko) 2002-11-14 2007-03-29 백융기 약학적으로 유용한 노화 및 스트레스 조절용 신규 페로몬 화합물 및 그 분리정제방법
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
WO2005118810A1 (en) 2004-06-03 2005-12-15 Athlomics Pty Ltd Agents and methods for diagnosing stress
EP1778213B1 (en) * 2004-07-16 2017-04-05 BTG International Limited A method for the synthesis of oligomeric compounds
WO2006020179A2 (en) * 2004-07-20 2006-02-23 Ketocytonyx Inc. Oligomeric ketone compounds
US20070225252A1 (en) * 2004-07-23 2007-09-27 Gross Richard A Ketogenic Saccharides
EP1793813A4 (en) * 2004-09-21 2011-05-18 Btg Int Ltd TREATMENT OF HYPERACTIVITY DISORDER WITH DEFICIT ATTENTION (ADHD)
WO2006034361A2 (en) * 2004-09-21 2006-03-30 Ketocytonyx Inc. Dopaminergic mimetics
US20090275670A1 (en) * 2008-04-30 2009-11-05 Marshall Gerald L Dog pheromone formulation and delivery system
FR2931676B1 (fr) * 2008-05-30 2011-01-14 Ceva Sante Animale Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
MX2011002895A (es) 2008-09-18 2011-04-11 Janssen Pharmaceutica Nv Uso de azaperona para reducir el uso de antibioticos.
MX376049B (es) 2008-10-16 2025-03-04 Ragasa Ind S A De C V Aceite vegetal de alta pureza dieléctrico, método para obtención y su aplicación en un aparato eléctrico.
US20100163029A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for administering an inhalable compound
US8871190B2 (en) 2009-04-25 2014-10-28 Sergeant's Pet Care Products, Inc. Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
WO2011084795A1 (en) * 2009-12-21 2011-07-14 Sergeant's Pet Care Products, Inc. Pheromone compositions and methods of use
CN103126886A (zh) * 2011-05-13 2013-06-05 中国农业科学院北京畜牧兽医研究所 一种仔猪安抚剂释放盒
CN102240279B (zh) * 2011-05-13 2013-04-10 中国农业科学院北京畜牧兽医研究所 一种仔猪安抚剂及其制备方法和应用
AU2012312310B2 (en) 2011-09-20 2016-04-28 Sergeants Pet Care Products, Inc. Interomone compositions and their use to modify behavior in different vertebrate species
US9480688B2 (en) 2011-09-20 2016-11-01 Sergeant's Pet Care Products, Inc. Pheromone compositions and their use to modify behavior in different vertebrate species
US9314018B2 (en) 2012-06-25 2016-04-19 Institut de Recherche en Semiochimie et Ethologie Appliquee Feline scratch marking semiochemicals
PL3119198T3 (pl) * 2014-03-18 2020-10-05 Institut de Recherche en Semiochimie et Ethologie Appliquée Kompozycje semiochemiczne do ograniczania konfliktów społecznych kotów
HRP20220957T1 (hr) 2014-03-18 2022-10-28 Institut de Recherche en Semiochimie et Ethologie Appliquée Feromon za umirivanje mačaka
EP2926809A1 (fr) * 2014-03-31 2015-10-07 Ceva Sante Animale Compositions à base de phéromones destinées à traiter les problèmes comportementaux ou médicaux liés au stress des mammifères non humains
FR3031039B1 (fr) 2014-12-24 2018-03-02 Virbac Composition apaisante pour animaux comprenant au moins un acide gras et de la nepetalactone
FR3031104B1 (fr) 2014-12-26 2017-01-06 Melchior Material & Life Science France Composition pro-pheromonale apaisante pour les mammiferes
CA2973626A1 (en) 2015-01-23 2016-07-28 Pork Crc Ltd Product and method for providing enrichment and facilitating expression of natural behaviours in pigs
CN107427485B (zh) * 2015-02-20 2021-06-18 雀巢产品有限公司 用于治疗焦虑症的中链脂肪酸及其甘油三酯
EP3124020A1 (en) 2015-07-31 2017-02-01 Ceva Sante Animale Pheromone compositions and uses thereof
FR3046334B1 (fr) 2015-12-31 2020-03-06 Melchior Material And Life Science France Composition solide pour le relargage controle de substances semiochimiques
WO2019083816A1 (en) 2017-10-23 2019-05-02 Epitracker, Inc. FATTY ACID ANALOGUES AND THEIR USE IN THE TREATMENT OF STATES RELATED TO METABOLIC SYNDROME
KR101994338B1 (ko) * 2017-10-25 2019-06-28 엘지이노텍 주식회사 사육장 관리 장치 및 방법
WO2019122424A1 (fr) 2017-12-22 2019-06-27 Ceva Sante Animale Diffuseurs de composition de semio-chimiques régulés en fonction de la température
CA3099482A1 (en) 2018-05-23 2019-11-28 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
WO2020146263A1 (en) 2019-01-09 2020-07-16 Epitracker, Inc. Compositions and methods for diagnosis and treatment of neurodegenerative diseases
EP3934639A4 (en) 2019-03-04 2023-01-11 Epitracker, Inc. FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE DISORDERS, BEHAVIORAL DISORDERS AND CHRONIC PAIN
BR112022004898A2 (pt) 2019-09-19 2022-06-07 J Mcglone John Feromônio neonatal materno de suíno
CA3171160A1 (en) * 2020-02-19 2021-08-26 Marel Meat A/S Method and system for pre-stunning and/or stunning animals
WO2022040346A1 (en) * 2020-08-20 2022-02-24 Epitracker, Inc. Compositions and methods for mood enhancement
KR20230097075A (ko) * 2020-10-19 2023-06-30 오레곤 스테이트 유니버시티 자폐 스펙트럼 장애를 치료하는 방법
CN112370528B (zh) * 2020-10-23 2022-04-08 宁波三生生物科技股份有限公司 一种具标识功能的信息素组合物及其制剂
JP2024539823A (ja) 2021-11-03 2024-10-31 エピトラッカー インコーポレイテッド 老化の質および寿命に関係する状態の治療のためのペンタデカノイルカルニチン
CN114452238B (zh) * 2022-01-07 2023-10-27 佛山市南海东方澳龙制药有限公司 具有安抚作用的宠物药浴香波及其制备方法
WO2023177427A1 (en) * 2022-03-14 2023-09-21 Fera Diagnostics And Biologicals Corp. Fatty acid compositions
CN117322521A (zh) * 2023-10-20 2024-01-02 中国农业大学 十五烷酸在缓解动物断奶应激中的应用
EP4595749A1 (en) 2024-02-02 2025-08-06 Signs Method of releasing a semiochemical in the environement by passive diffusion, system and means, especially sticks, to this end, and uses thereof
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61249371A (ja) * 1985-04-30 1986-11-06 Nippon Oil & Fats Co Ltd 栄養飲料組成物
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
ES2034888B1 (es) * 1991-07-11 1994-02-16 Madaus Cerafarm Lab Procedimiento de obtencion de la fraccion acida total de los extractos lipidicos de los frutos del sabal serrulata.
US5425963A (en) * 1991-09-17 1995-06-20 Church & Dwight Co., Inc. High purity fatty acid salt products
WO1993011987A1 (fr) * 1991-12-13 1993-06-24 Viktor Nikolaevich Kizilov Vehicule sur coussin d'air
SE9200541D0 (sv) * 1992-02-24 1992-02-24 Kabi Pharmacia Ab New usee of omega-3-fatty acids
AU3472193A (en) * 1992-03-20 1993-10-21 Church & Dwight Company, Inc. Encapsulated dietary fatty acid salt products
DE69420124T2 (de) * 1993-01-15 2000-03-02 Abbott Laboratories, Abbott Park Strukturierte lipide
ATE185046T1 (de) * 1995-02-03 1999-10-15 Fideline Eigenschaften von gesichtpheromonen von katzen
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
JP4754688B2 (ja) * 1998-01-21 2011-08-24 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン

Also Published As

Publication number Publication date
CA2227706A1 (en) 1999-07-21
DE69922633D1 (de) 2005-01-20
HU226882B1 (en) 2010-01-28
NO308197B1 (no) 2000-08-14
DE69814343T2 (de) 2003-12-24
ATE284688T1 (de) 2005-01-15
JP4750232B2 (ja) 2011-08-17
SK10902000A3 (sk) 2001-02-12
BRPI9907151B1 (pt) 2016-02-16
EP1047415B1 (en) 2004-12-15
AU2423799A (en) 1999-08-09
BRPI9907151C1 (pt) 2021-05-25
ZA99426B (en) 1999-07-21
CA2318392A1 (en) 1999-07-29
NO980282D0 (no) 1998-01-21
AU760614B2 (en) 2003-05-22
NO20003693D0 (no) 2000-07-19
PL341867A1 (en) 2001-05-07
PT1047415E (pt) 2005-04-29
CZ20002700A3 (cs) 2000-12-13
NO329205B1 (no) 2010-09-13
NO980282L (no) 1999-07-22
CN1217659C (zh) 2005-09-07
IL137257A0 (en) 2001-07-24
BR9907151A (pt) 2000-10-24
PT948963E (pt) 2003-09-30
DK0948963T3 (da) 2003-08-11
US6077867A (en) 2000-06-20
SK285905B6 (sk) 2007-10-04
PL199144B1 (pl) 2008-08-29
ES2198661T3 (es) 2004-02-01
CA2227706C (en) 2010-08-03
CA2318392C (en) 2011-11-15
ATE239464T1 (de) 2003-05-15
CN1291093A (zh) 2001-04-11
BRPI9907151B8 (pt) 2017-11-14
ES2234236T3 (es) 2005-06-16
DK1047415T3 (da) 2005-04-25
NZ505813A (en) 2003-07-25
US6384252B1 (en) 2002-05-07
JPH11209293A (ja) 1999-08-03
WO1999037297A1 (en) 1999-07-29
EP1047415A1 (en) 2000-11-02
EP0948963A1 (en) 1999-10-13
EP0948963B1 (en) 2003-05-07
DE69922633T2 (de) 2005-12-15
DE69814343D1 (de) 2003-06-12
HUP0101312A2 (hu) 2001-08-28
HUP0101312A3 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
NO20003693L (no) Beroligende feromoner for svin for Õ minske stress, angst og aggressivitet
DE69505128D1 (de) Verfahren zur herstellung von trihydrat von (2r,3s)-3-tert-butoxycarbonyl-amino-2-hydroxy-3-phenylpropionylsäure ester von 4-acetoxy-2alfa-benzoyloxy-5beta, 20-epoxy-1,7beta, 10beta-trihydroxy-9-oxo-tax-11-en-13alfa-yl
DE60034919D1 (de) Kosmetische Zubereitung Ester hydroxylierter Fettsäuren enthaltend
DK657287D0 (da) Fremgangsmaade til kontinuerlig fraktionering af en blanding af fedtsyrer
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ES2127022T3 (es) Aditivos y composiciones de fueloleo.
DK0878997T3 (da) Spiselig vegetabilsk fedtstofsammensætning
ATE160378T1 (de) Verfahren zur herstellung von glykosid-estern und zusammensetzungen daraus
ES2118629T3 (es) Mezcla de grasas conteniendo fosfolipidos con acidos grasos lcp
DK0710477T3 (da) Lipidsammensætning til kosmetiske produkter
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
ATE401898T1 (de) Phosphatidyl-l-serin und phosphatidylsäure zur behandlung von depression und stresszuständen
ATE125426T1 (de) Verbesserte, auf triglycerid-additiven basierte schokoladezusammensetzungen.
DE69315827D1 (de) Neue acylierte phospholipid-arzneimittel
ATE228556T1 (de) An omega-3 ungesättigten fettsäuren angereicherte wachsester, ihre herstellung und verwendung
ATE468123T1 (de) Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
ATE312604T1 (de) Kombinationspräparat aus omega-3-fettsäuren und konjugierten linolsäuren zur behandlung immunologisch geprägter krankheitsbilder
ATE465158T1 (de) Anwendungen von tocopherolestern

Legal Events

Date Code Title Description
MK1K Patent expired